Literature DB >> 10955408

Marginal structural models and causal inference in epidemiology.

J M Robins1, M A Hernán, B Brumback.   

Abstract

In observational studies with exposures or treatments that vary over time, standard approaches for adjustment of confounding are biased when there exist time-dependent confounders that are also affected by previous treatment. This paper introduces marginal structural models, a new class of causal models that allow for improved adjustment of confounding in those situations. The parameters of a marginal structural model can be consistently estimated using a new class of estimators, the inverse-probability-of-treatment weighted estimators.

Mesh:

Substances:

Year:  2000        PMID: 10955408     DOI: 10.1097/00001648-200009000-00011

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  1536 in total

1.  Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis.

Authors:  Kate L Lapane; Shibing Yang; Jeffrey B Driban; Shao-Hsien Liu; Catherine E Dubé; Timothy E McAlindon; Charles B Eaton
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

2.  MOVING TO INEQUALITY: NEIGHBORHOOD EFFECTS AND EXPERIMENTS MEET STRUCTURE.

Authors:  Robert J Sampson
Journal:  AJS       Date:  2008-07

3.  Quantifying Cancer Risk from Radiation.

Authors:  Alexander P Keil; David B Richardson
Journal:  Risk Anal       Date:  2017-12-06       Impact factor: 4.000

4.  Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.

Authors:  Vincent Lo Re; Bret Zeldow; Michael J Kallan; Janet P Tate; Dena M Carbonari; Sean Hennessy; Jay R Kostman; Joseph K Lim; Matthew Bidwell Goetz; Robert Gross; Amy C Justice; Jason A Roy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-19       Impact factor: 2.890

5.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

6.  Latent Class Dynamic Mediation Model with Application to Smoking Cessation Data.

Authors:  Jing Huang; Ying Yuan; David Wetter
Journal:  Psychometrika       Date:  2019-01-03       Impact factor: 2.500

7.  Anesthesia provider model, hospital resources, and maternal outcomes.

Authors:  Jack Needleman; Ann F Minnick
Journal:  Health Serv Res       Date:  2008-11-04       Impact factor: 3.402

8.  Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.

Authors:  E T Overton; D Kitch; C A Benson; P W Hunt; J H Stein; M Smurzynski; H J Ribaudo; P Tebas
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

9.  Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women.

Authors:  Brian W Whitcomb; Sunni L Mumford; Neil J Perkins; Jean Wactawski-Wende; Elizabeth R Bertone-Johnson; Kristine E Lynch; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

10.  Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.

Authors:  Jeffrey P Anderson; Eric J Tchetgen Tchetgen; Vincent Lo Re; Janet P Tate; Paige L Williams; George R Seage; C Robert Horsburgh; Joseph K Lim; Matthew Bidwell Goetz; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Marina B Klein; Amy C Justice
Journal:  Clin Infect Dis       Date:  2013-11-27       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.